Given the above findings, we performed phosphatidylinositol-3,4,5-trisphosphate (PIP3) phosphatase assays to validate the effect of TET1 on PTEN activity in thyroid cancer cells. This evidence concerns the gene TET1 and thyroid gland carcinoma.